Acadia Healthcare Company (ACHC) Cash & Equivalents (2010 - 2026)

Acadia Healthcare Company has disclosed Cash & Equivalents across 17 years of filings, most recently posting $158.5 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 73.69% year-over-year to $158.5 million; the TTM figure through Mar 2026 stood at $158.5 million (up 73.69% YoY), while the FY2025 annual figure was $133.2 million, up 74.62% from the prior year.
• Cash & Equivalents improved to $158.5 million in Q1 2026, from $133.2 million in the prior quarter.
• Over the last five years, Cash & Equivalents for ACHC reached as high as $158.5 million in Q1 2026 and fell as low as $63.8 million in Q1 2023.
• The 5-year median for Cash & Equivalents is $99.6 million (2023), against an average of $104.8 million.
• Annual changes were most pronounced in 2023 — Cash & Equivalents slumped 54.53% — and 2025, when it soared 74.62%.
• A 5-year view of Cash & Equivalents shows it stood at $97.6 million in 2022, then increased by 2.48% to $100.1 million in 2023, then decreased by 23.75% to $76.3 million in 2024, then soared by 74.62% to $133.2 million in 2025, then increased by 18.94% to $158.5 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $158.5 million, $133.2 million, and $118.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.